Cambridge Apollometadata only
Sumatriptan, a serotonin 5HT1B receptor agonist, acutely reduces insulin secretion and sensitivity and glucose effectiveness in overweight humans: A double-blinded placebo-controlled cross-over trial.
beta cell function, drug mechanism, effectiveness, glycaemic control, insulin secretion, randomised trial, adult, animals
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 640290
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.